+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Peptide Therapeutics Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Type, Route of Administration, Synthesis Technology, Liquid Phase Peptide Synthesis, and Hybrid Technology), and Application, and Geography

  • ID: 5308769
  • Report
  • February 2021
  • Region: Global
  • The Insight Partners
UP TO OFF until Jun 30th 2022

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • EVER Pharma GmbH
  • Glaxosmithkline PLC
  • Novo Nordisk A/S
The peptide therapeutics market was valued at US$ 24,878.55 million in 2019 and is projected to reach US$ 50,003.15 million by 2027; it is expected to grow at a CAGR of 9.11% from 2019 to 2027. The growth of the peptide therapeutics market is mainly attributed to the growing investments on peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides deter the market growth.



Continuous R&D activities in peptide therapeutics have discovered its benefits in tackling a range of chronic disorders, such as renal disorders, genetic conditions, oncology, and neurodegenerative conditions. The effectiveness of the outcomes of peptide therapies is generating investments in the development of new drugs. For instance, in December 2020, Peptilogics received funding of around US$ 35.4 million through the rounds of series funding. The funding would accelerate the development of its peptide therapeutics pipeline candidate, PLG0206. Moreover, in October 2020, Lassogen raised US$ 4.5 million through the rounds of series funding for the development of lasso peptides. According to the company, the peptide is expected to offer superior treatment outcomes for cancer, autoimmunity, pain, and inflammation. Further, in December 2020, ONL Therapeutics closed rounds of series funding (US$ 46.9 million) for its ONL1204 peptide candidate for retinal diseases.

The companies are also focusing on extended investments to expand their operations in the peptide market. For instance, in March 2019, Creative Peptides, a US-based company launched its new pharmaceutical peptides services with an aim to extend the applications of peptides for drug discovery. Moreover, in October 2019, UCB announced its plan to acquire RA Pharmaceuticals to increase its peptide drug portfolio. At present, RA Pharmaceutical has its product in pipeline. Such investments are expected to accelerate the growth of the peptide therapeutics market during the forecast period.

Increasing utilization of peptide molecules for the development of COVID-19 vaccine is estimated to have a positive impact on the market growth. Moreover, extensive support from government authorities for the use of peptides for COVID-19 vaccine development is also anticipated to offer potential opportunity for the adoption of peptides, which will eventually accelerate the growth of peptide therapeutics market.

Based on type, the peptide therapeutics market is segmented into innovative and generics. The innovative segment held a larger share of the market in 2019; however, the generics segment is estimated to register a higher CAGR during the forecast period.

Based on route of administration, the peptide therapeutics market is segmented into parenteral, mucosal, oral, pulmonary, and others. The parenteral segment held the largest share of the market in 2019; however, the oral segment is estimated to register the highest CAGR during the forecast period.

Based on synthesis technology, the peptide therapeutics market is segmented into solid phase peptide synthesis (SPPS), liquid phase peptide synthesis (LPPS), and hybrid technology. The solid phase peptide synthesis (SPPS) segment held the largest share of the market in 2019; however, hybrid technology segment is estimated to register the highest CAGR during the forecast period.

Based on application, the peptide therapeutics market is segmented into cancer, metabolic disorder, cardiovascular disorder, respiratory disorder, pain, and dermatology. The cancer segment held the largest share of the market in 2019; however, metabolic disorders segment is estimated to register the highest CAGR during the forecast period.

The World Health Organization (WHO), Food and Drug Administration (FDA), National Health Service (NHS), and Centers for Disease Control and Prevention (CDC) are among the major primary and secondary sources referred to while preparing this report.
Frequently Asked Questions about the Peptide Therapeutics Market

What is the estimated value of the Peptide Therapeutics Market?

The Peptide Therapeutics Market was estimated to be valued at $24878.6 Million in 2019.

What is the growth rate of the Peptide Therapeutics Market?

The growth rate of the Peptide Therapeutics Market is 9.1%, with an estimated value of $50003.2 Million by 2027.

What is the forecasted size of the Peptide Therapeutics Market?

The Peptide Therapeutics Market is estimated to be worth $50003.2 Million by 2027.

Who are the key companies in the Peptide Therapeutics Market?

Key companies in the Peptide Therapeutics Market include Eli Lilly and Company, Amgen Inc., TEVA PHARMACEUTICAL INDUSTRIES LTD, Polypeptide Group, EVER Pharma GmbH, Bristol, Myers Squibb Company, Novo Nordisk A/S and AstraZeneca PLC.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen Inc.
  • AstraZeneca PLC
  • Eli Lilly and Company
  • EVER Pharma GmbH
  • Glaxosmithkline PLC
  • Novo Nordisk A/S

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Peptide Therapeutics Market - By Type
1.3.2 Global Peptide Therapeutics Market - By Route of Administration
1.3.3 Global Peptide Therapeutics Market - By Synthesis Technology
1.3.4 Global Peptide Therapeutics Market - By Application
1.3.5 Global Peptide Therapeutics Market - By Geography
2. Peptide Therapeutics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Peptide Therapeutics - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe - PEST Analysis
4.2.3 Asia Pacific - PEST Analysis
4.2.4 Middle East and Africa (MEA) - PEST Analysis
4.2.5 South and Central America (SCAM) - PEST Analysis
4.3 Expert Opinion
5. Peptide Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Investments on Peptide Therapeutics
5.1.2 Increasing Prevalence of Metabolic Disorders and Infectious Diseases
5.2 Market Restraints
5.2.1 Operational Limitations of Peptides
5.3 Market Opportunities
5.3.1 Strong Pipeline and Applications of Peptide Drugs
5.4 Future Trends
5.4.1 Emphasis on Automatic Peptide Synthesis
5.5 Impact Analysis
6. Peptide Therapeutics Market - Global Analysis
6.1 Global Peptide Therapeutics Market Revenue Forecast And Analysis
6.2 Global Peptide Therapeutics Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Peptide Therapeutics Market Analysis - By Type
7.1 Overview
7.2 Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
7.3 Generic
7.3.1 Overview
7.3.2 Generic: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
7.4 Innovative
7.4.1 Overview
7.4.2 Innovative: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8. Peptide Therapeutics Market Analysis - By Route of Administration
8.1 Overview
8.2 Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.5 Mucosal
8.5.1 Overview
8.5.2 Mucosal: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.6 Pulmonary
8.6.1 Overview
8.6.2 Pulmonary: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9. Peptide Therapeutics Market Analysis - By Synthesis Technology
9.1 Overview
9.2 Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
9.3 Solid Phase Peptide Synthesis (SPPS)
9.3.1 Overview
9.3.2 Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9.4 Liquid Phase Peptide Synthesis (LPPS)
9.4.1 Overview
9.4.2 Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
9.5 Hybrid Technology
9.5.1 Overview
9.5.2 Hybrid Technology: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
10. Peptide Therapeutics Market- Application
10.1 Overview
10.2 Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
10.3 Cancer
10.3.1 Overview
10.3.2 Cancer: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.4 Cardiovascular Disorders
10.4.1 Overview
10.4.2 Cardiovascular Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.6 Respiratory Disorders
10.6.1 Overview
10.6.2 Respiratory Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.7 Pain
10.7.1 Overview
10.7.2 Pain: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
11. Peptide Therapeutics Market - Geographic Analysis
11.1 North America: Peptide Therapeutics Market
11.1.1 Overview
11.1.2 North America: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.1.4 North America: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.5 North America: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.1.6 North America: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.7 North America: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
11.1.8 US: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.1.8.3 US: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.8.4 US: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.1.8.5 US: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.9 Canada: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.1.9.3 Canada: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.9.4 Canada: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.1.9.5 Canada: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.1.10 Mexico: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.1.10.3 Mexico: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.1.10.4 Mexico: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.1.10.5 Mexico: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2 Europe: Peptide Therapeutics Market
11.2.1 Overview
11.2.2 Europe: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.4 Europe: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.5 Europe: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.6 Europe: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2.7 Europe: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
11.2.8 Germany: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.8.3 Germany: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.8.4 Germany: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.8.5 Germany: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2.9 UK: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.9.3 UK: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.9.4 UK: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.9.5 UK: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2.10 France: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.10.3 France: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.10.4 France: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.10.5 France: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2.11 Spain: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.11.3 Spain: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.11.4 Spain: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.11.5 Spain: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2.12 Italy: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.12.3 Italy: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.12.4 Italy: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.12.5 Italy: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.2.13 Rest of Europe: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.13.1 Rest of Europe: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.2.13.2 Rest of Europe: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.2.13.3 Rest of Europe: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.2.13.4 Rest of Europe: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.2.13.5 Rest of Europe: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3 Asia Pacific: Peptide Therapeutics Market
11.3.1 Overview
11.3.2 Asia Pacific: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.4 Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.5 Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.6 Asia Pacific: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.7 Asia Pacific: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
11.3.8 China: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.8.3 China: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.8.4 China: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.8.5 China: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.9 Japan: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.9.3 Japan: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.9.4 Japan: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.9.5 Japan: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.10 India: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.10.3 India: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.10.4 India: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.10.5 India: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.11 South Korea: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.11.3 South Korea: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.11.4 South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.11.5 South Korea: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.12 Australia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.12.3 Australia: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.12.4 Australia: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.12.5 Australia: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.3.13 Rest of Asia Pacific: Peptide Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)
11.3.13.1 Rest of Asia Pacific: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)
11.3.13.2 Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.3.13.3 Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.3.13.4 Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.3.13.5 Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.4 Middle East & Africa: Peptide Therapeutics Market
11.4.1 Overview
11.4.2 Middle East & Africa: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East and Africa: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.4.4 Middle East and Africa: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.5 Middle East and Africa: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.4.6 Middle East and Africa: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.4.7 Middle East & Africa: Peptide Therapeutics Market Share by Country - 2019 & 2027, (%)
11.4.8 Saudi Arabia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.4.8.3 Saudi Arabia: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.8.4 Saudi Arabia: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.4.8.5 Saudi Arabia: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.4.9 UAE: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.4.9.3 UAE: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.9.4 UAE: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.4.9.5 UAE: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.4.10 South Africa: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
11.4.10.1 South Africa: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.4.10.3 South Africa: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.10.4 South Africa: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.4.10.5 South Africa: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.4.11 Rest of Middle East and Africa: Peptide Therapeutics Market - Revenue and Forecasts to 2027 (USD Million)
11.4.11.1 Rest of Middle East and Africa: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)
11.4.11.2 Rest of Middle East and Africa: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.4.11.3 Rest of Middle East and Africa: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.4.11.4 Rest of Middle East and Africa: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.4.11.5 Rest of Middle East and Africa: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5 South and Central America: Peptide Therapeutics Market
11.5.1 Overview
11.5.2 South and Central America: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
11.5.3 South and Central America: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.5.4 South and Central America: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.5 South and Central America: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.5.6 South and Central America: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5.7 South and Central America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)
11.5.8 Brazil: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.5.8.3 Brazil: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.8.4 Brazil: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.5.8.5 Brazil: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5.9 Argentina: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.5.9.3 Argentina: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.9.4 Argentina: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.5.9.5 Argentina: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
11.5.10 Rest of South and Central America: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)
11.5.10.1 Rest of South and Central America: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)
11.5.10.2 Rest of South and Central America: Peptide Therapeutics Market, by Type, 2018-2027 (USD Million)
11.5.10.3 Rest of South and Central America: Peptide Therapeutics Market, by Route of Administration, 2018-2027 (USD Million)
11.5.10.4 Rest of South and Central America: Peptide Therapeutics Market, by Synthesis Technology, 2018-2027 (USD Million)
11.5.10.5 Rest of South and Central America: Peptide Therapeutics Market, by Application, 2018-2027 (USD Million)
12. Impact of COVID-19 Pandemic on Global Peptide Therapeutics Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
12.5 South and Central America: Impact Assessment of COVID-19 Pandemic
13. Peptide Therapeutics Market- Industry Landscape
13.1 Overview
13.1 Growth Strategies Done by the Companies in the Market, (%)
13.2 Organic Developments
13.2.1 Overview
13.3 Inorganic Developments
13.3.1 Overview
14. Company Profiles
14.1 Amgen Inc.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 Eli Lilly and Company
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 EVER Pharma GmbH
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Polypeptide Group
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 TEVA PHARMACEUTICAL INDUSTRIES LTD
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 AstraZeneca
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Bristol-Myers Squibb Company
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 GlaxoSmithKline plc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Novo Nordisk A/S
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 Sanofi
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About the Publisher
15.2 Glossary of Terms
List of Tables
Table 1. North America Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 2. North America Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 3. North America Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 4. North America Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 5. US Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 6. US Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 7. US Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 8. US Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 9. Canada Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 13. Mexico Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 15. Mexico Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 17. Europe Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Europe Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 21. Germany Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Germany Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 23. Germany Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 24. Germany Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 25. UK Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 26. UK Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 27. UK Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 28. UK Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 29. France Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 30. France Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 31. France Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 32. France Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 33. Spain Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 34. Spain Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 35. Spain Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 36. Spain Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 37. Italy Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 38. Italy Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 39. Italy Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 40. Italy Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 41. Rest of Europe Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 42. Rest of Europe Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 43. Rest of Europe Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 44. Rest of Europe Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 45. Asia Pacific Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 46. Asia Pacific Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 47. Asia Pacific Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 48. Asia Pacific Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 49. China Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 50. China Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 51. China Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 52. China Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 53. Japan Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 54. Japan Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 55. Japan Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 56. Japan Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 57. India Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 58. India Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 59. India Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 60. India Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 61. South Korea Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 62. South Korea Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 63. South Korea Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 65. Australia Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 66. Australia Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 67. Australia Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 68. Australia Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 69. Rest of Asia Pacific Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 70. Rest of Asia Pacific Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 71. Rest of Asia Pacific Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 72. Rest of Asia Pacific Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 73. Middle East and Africa Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 74. Middle East and Africa Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East and Africa Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 76. Middle East and Africa Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 77. Saudi Arabia Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 78. Saudi Arabia Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 80. Saudi Arabia Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 81. UAE Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 82. UAE Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 83. UAE Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 84. UAE Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 85. South Africa Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 86. South Africa Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 87. South Africa Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 88. South Africa Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 89. Rest of Middle East and Africa Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 90. Rest of Middle East and Africa Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 91. Rest of Middle East and Africa Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 92. Rest of Middle East and Africa Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 93. South and Central America Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 94. South and Central America Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 95. South and Central America Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 96. South and Central America Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 97. Brazil Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 98. Brazil Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 99. Brazil Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 100. Brazil Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 101. Argentina Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 102. Argentina Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 103. Argentina Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 104. Argentina Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 105. Rest of South and Central America Peptide Therapeutics Market, by Type - Revenue and Forecast to 2027 (USD Million)
Table 106. Rest of South and Central America Peptide Therapeutics Market, by Route of Administration - Revenue and Forecast to 2027 (USD Million)
Table 107. Rest of South and Central America Peptide Therapeutics Market, by Synthesis Technology - Revenue and Forecast to 2027 (USD Million)
Table 108. Rest of South and Central America Peptide Therapeutics Market, by Application - Revenue and Forecast to 2027 (USD Million)
Table 109. Organic Developments Done by Companies
Table 110. Inorganic Developments Done by Companies
Table 111. Glossary of Terms, Peptide Therapeutics Market
List of Figures
Figure 1. Peptide Therapeutics Market Segmentation
Figure 2. Peptide Therapeutics Market Segmentation, By Region
Figure 3. Global Peptide Therapeutics Market Overview
Figure 4. Innovative Segment Held Largest Share of Peptide Therapeutics Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Peptide Therapeutics Market, by Geography (US$ Million)
Figure 7. Global Peptide Therapeutics Market - Leading Country Markets (US$ Million)
Figure 8. Global Peptide Therapeutics Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Peptide Therapeutics Market Impact Analysis of Drivers and Restraints
Figure 15. Global Peptide Therapeutics Market - Revenue Forecast and Analysis - 2019- 2027
Figure 16. Global Peptide Therapeutics Market - By Geography Forecast and Analysis - 2019- 2027
Figure 17. Market Positioning of Key Players in Global Peptide Therapeutics Market
Figure 18. Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
Figure 19. Generic: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 20. Innovative: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 21. Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 22. Parenteral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 23. Oral: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 24. Mucosal: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 25. Pulmonary: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 26. Others: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 27. Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
Figure 28. Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 29. Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 30. Hybrid Technology: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 31. Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
Figure 32. Cancer: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 33. Cardiovascular Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 34. Metabolic Disorder: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 35. Respiratory Disorders: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 36. Pain: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 37. Dermatology: Peptide Therapeutics Market Market- Revenue and Forecast to 2027 (US$ million)
Figure 38. North America: Peptide Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 39. North America Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 40. North America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 41. US: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 42. Canada: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 43. Mexico: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 44. Europe: Peptide Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 45. Europe Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 46. Europe: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
Figure 47. Germany: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 48. UK: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 49. France: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 50. Spain: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 51. Italy: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 52. Rest of Europe: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 53. Asia Pacific: Peptide Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 54. Asia Pacific Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 55. China: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 56. Japan: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 57. India: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 58. South Korea: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 59. Australia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 60. Rest of Asia Pacific: Peptide Therapeutics Market- Revenue And Forecasts To 2027 (USD Million)
Figure 61. Middle East & Africa: Peptide Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 62. Middle East & Africa Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 63. Middle East & Africa: Peptide Therapeutics Market Share by Country - 2019 & 2027, (%)
Figure 64. Saudi Arabia: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 65. UAE: Peptide Therapeutics Market - Revenue and Forecast to 2027 (US$ Million)
Figure 66. South Africa: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 67. Rest of Middle East and Africa: Peptide Therapeutics Market- Revenue And Forecasts To 2027 (USD Million)
Figure 68. South and Central America: Peptide Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 69. South and Central America Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 70. South and Central America: Peptide Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 71. Brazil: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 72. Argentina: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 73. Rest of South and Central America: Peptide Therapeutics Market- Revenue And Forecasts To 2027 (USD Million)
Figure 74. Impact of COVID-19 Pandemic in North America Country Markets
Figure 75. Impact of COVID-19 Pandemic in European Country Markets
Figure 76. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 77. Impact of COVID-19 Pandemic in Middle East and Africa Market
Figure 78. Impact of COVID-19 Pandemic in South and Central America Market
Figure 79. Growth Strategies Done by the Companies in the Market, (%)
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Eli Lilly and Company
  • Amgen Inc.
  • TEVA PHARMACEUTICAL INDUSTRIES LTD
  • Polypeptide Group
  • EVER Pharma GmbH
  • Bristol-Myers Squibb Company
  • Novo Nordisk A/S
  • Sanofi
  • AstraZeneca PLC
  • Glaxosmithkline PLC
Note: Product cover images may vary from those shown